“We found that the SAPS is associated with higher intrarenal pressure and flow rate when compared to automated pumps," said Lucas B. Vergamini, MD.
A study evaluating intrarenal pressure and flow rate with several different irrigation methods and other variables demonstrated that both larger ureteral access sheath size and working channel occupant are linked with reduced intrarenal pressure.1
Intrarenal pressure was significantly higher when using a 11/13Fr ureteral access sheath compared with a 12/14Fr sheath (P < .01).
“We know that irrigation is vital in endourology to provide us with good visualization during the procedure, and pressurized irrigation is sometimes used to achieve that goal. However, by increasing flow rate that usually is followed by increasing intrarenal pressure, which has become of increased concern in recent years,” said Lucas B. Vergamini, MD, a research fellow at the University of Kansas Medical Center in Kansas City. Vergamini presented the findings at the 2024 American Urological Association Annual Meeting in San Antonio, Texas.
Boston Scientific recently released the LithoVue Elite flexible ureteroscope, which monitors intrarenal pressure. For the study, the investigators used the LithoVue Elite to report real-time intrarenal pressure and flow rate with several different irrigation systems in an ex vivo model of a porcine kidney/ureter. The Single-Action Pumping System (SAPS), Thermedx FluidSmart, and ENDOMAT were all used in the study.The automated pumps used pressures of 50 mmHg, 100 mmHg, and 150 mmHg, whereas the SAPS incorporated standardized movements applied by the same member of the research team. Working channel occupant options included none, a 200-µm laser fiber, a 365-µm laser fiber, and a 1.9Fr ZeroTip Nitinol Retrieval Basket. Ureteral access sheath options included none; an 11/13Fr, 36 cm; and an 12/14Fr, 36 cm. Different ureteroscopic settings were tested across all permutations of irrigation method, working channel use, and presence or absence of a ureteral access sheath, according to the authors. Eighty-four ureteroscopic settings were tested for a total of 252 experiments.
According to the authors, ENDOMAT had a higher intrarenal pressure than Thermedx at 50 mmHg and 100 mmHg. The SAPS had higher intrarenal pressure and flow rates than both ENDOMAT and Thermedx FluidSmart across ureteroscopic settings (P < .01). In addition, intrarenal pressure was significantly higher when using a 11/13Fr ureteral access sheath compared with a 12/14Fr sheath (P < .01).
“A strong positive correlation was seen between pressure set by the pump and both [intrarenal pressure] and [flow rate],” wrote the authors.
“We found that the SAPS is associated with higher intrarenal pressure and flow rate when compared to automated pumps. As we increase the diameter of the working channel…we see that there is a decrease in intrarenal pressure for the automated pumps and also a decrease of flow rate. We would also like to state that in any of those situations, neither automated pumps or SAPS ever reached mean intrarenal pressure over 30 mm of mercury, which is the threshold for pyelovenous backflow,” Vergamini said.
The authors concluded that live experiment models are necessary in order "to evaluate the impact of ureter contracture in [intrarenal pressure] and [flow rate]."
REFERENCE
1. Vergamini LB, Ito W, Tverye A, et al. Intrarenal pressure and flow rate profile using Lithovue Elite™: impact of different irrigation systems and working channel use. Presented at: 2024 American Urological Association Annual Meeting. May 3-6, San Antonio, Texas. MP43-10
Bundled payment program covers kidney stone care
July 22nd 2024"One day, we're going to have to move away from fee for service, so we'd be wise to try to navigate those waters ahead of time, so we're not left dealing with the aftermath when someone else has implemented it for us," says Ruchika Talwar, MD.
FDA grants 510(k) clearance to Ambu’s single-use ureteroscope
July 2nd 2024"This clearance in the US of our new ureteroscopy solution not only demonstrates a market expansion for Ambu; it is a testament to the progressive shift towards single-use solutions within the field of urology," says Britt Meelby Jensen.
Study evaluates weight management and prostate cancer progression, QOL
June 12th 2024"To me, the most compelling outcome is really the quality-of-life outcomes. General quality of life as well as emotional quality of life improved in the intervention group significantly," says Jill M. Hamilton Reeves, PhD, RD, CSO.
Data support shock wave lithotripsy for pediatric patients with kidney stones
May 28th 2024Regarding patient-reported outcomes, those who underwent URS showed higher urinary symptoms, greater pain intensity, and greater pain interference at 1 week following surgery compared with those who underwent SWL.